Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q3 2023 Earnings Call Transcript

Christina Shafer: Yes. Thanks, Doug. I think one thing that Scott mentioned was just the infrastructure that it would take for a promotional effort inside of the ER, which I think we could all say is pretty robust. And so who we are as Marinus is really focusing on an unmet medical need. And the total value proposition in the SRSE population is quite large. And what we mean by total value proposition is not only the economic value proposition, but the clinical value that we could potentially bring is quite large. When we look at cost of care inside the hospital system and moving and progressing through status, it grows significantly as it gets to SRSE. And if we’re focusing on an unmet medical need, these patients are in dire need, and these healthcare providers really need something that is effective for these patients.

And we’ve been encouraged what Joe’s team has shown us with some of the patients that have been treated, and we know that these patients are definitely responsive in given circumstances. So again, looking at the economic and clinical value prop for these patients is quite large.

Operator: Thank you. That’s all the time we have for questions today. I will now turn the call over to Scott for some closing remarks.

Scott Braunstein: Well, thanks everyone for dialing in. Sorry that we couldn’t get to all the Q&A today. I will openly admit that I’m a little bit under the weather and a little bit of a struggle for me to get through this call today, but I appreciate you all dialing in. And we are keeping our heads down, and we’ll be working to the finish line on both of these studies, which we’re incredibly excited about. Commercial team continues to do just a fantastic job. And we didn’t spend any time on it on the call today, but we will continue to expect to have data on our second generation program by year end. It’s one that we’re incredibly excited about as well. So thank you all for dialing in, and we look forward to getting to the finish line on these studies, and we’ll be in touch with you all shortly. Thanks so much.

Operator: This concludes today’s conference call. You may now disconnect.